聚隆科技(300475.SZ)擬按“10配1”進行配售 募資不超7億元
格隆匯9月16日丨聚隆科技(300475.SZ)發佈2021年度配股向不特定對象發行證券預案,公司按每10股配售1股的比例向全體股東配售。此次配售股票數量以實施配股方案的股權登記日收市後的A股股票總數為基數確定。若以公司2021年6月30日的總股本4.2億股計算,則可配售數量共計4200萬股。
此次配股募集資金總額不超過7億元人民幣(含),扣除發行費用後的募集資金淨額將全部用於補充流動資金,以滿足公司及聯合創泰相關業務不斷髮展對營運資金的需求,進而促進公司主營業務持續健康發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.